Literature DB >> 9271079

Peptidyl inverse esters of p-methoxybenzoic acid: a novel class of potent inactivator of the serine proteases.

J Lynas1, B Walker.   

Abstract

A series of novel synthetic peptides, containing a C-terminal beta-amino alcohol linked to p-methoxybenzoic acid via an ester linkage, have been prepared and tested as inhibitors against typical members of the serine protease family. For example, the sequences Ac-Val-Pro-NH-CH-(CH2-C6H5)-CH2O-CO-C6H4-OCH3 (I) and Ac-Val-Pro-NH-CH-[CH-(CH3)2]-CH2O-CO-C6H4-OCH3 (II), which fulfil the known primary and secondary specificity requirements of chymotrypsin and elastase respectively, have been found to behave as exceptionally potent irreversible inactivators of their respective target protease. Thus I was found to inactivate chymotrypsin with an overall second-order rate constant (k2/Ki) of approx. 6.6x10(6) M-1. s-1, whereas II is an even more potent inactivator of human neutrophil elastase, exhibiting a second-order rate constant of inactivation of approx. 1.3x10(7) M-1.s-1. These values represent the largest rate constants ever reported for the inactivation of these proteases with synthetic peptide-based inactivators. On prolonged incubation in substrate-containing buffers, samples of the inactivated proteases were found to regain activity slowly. The first-order rate constants for the regeneration of enzymic activity from chymotrypsin and human neutrophil elastase inactivated by I and II respectively were determined to be approx. 5.8x10(-5) s-1 and approx. 4.3x10(-4) s-1. We believe that the most likely mechanism for the inactivation and regeneration of enzymic activity involves the formation and subsequent slow hydrolysis of long-lived acyl enzyme intermediates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271079      PMCID: PMC1218602          DOI: 10.1042/bj3250609

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

2.  Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones.

Authors:  J C Powers; B F Gupton; A D Harley; N Nishino; R J Whitley
Journal:  Biochim Biophys Acta       Date:  1977-11-23

3.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 4.  Evolution of proteolytic enzymes.

Authors:  H Neurath
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

5.  Avidin is a slow-binding inhibitor of pyruvate carboxylase.

Authors:  R G Duggleby; P V Attwood; J C Wallace; D B Keech
Journal:  Biochemistry       Date:  1982-07-06       Impact factor: 3.162

6.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

Authors:  C Kettner; E Shaw
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  A new class of heterocyclic serine protease inhibitors. Inhibition of human leukocyte elastase, porcine pancreatic elastase, cathepsin G, and bovine chymotrypsin A alpha with substituted benzoxazinones, quinazolines, and anthranilates.

Authors:  T Teshima; J C Griffin; J C Powers
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

8.  The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.

Authors:  B Walker; D T Elmore
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

9.  Suicide inactivation of chymotrypsin by benzoxazinones.

Authors:  L Hedstrom; A R Moorman; J Dobbs; R H Abeles
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

10.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.